Free · 13,591 studies indexed

lighttherapyresearch.com is a free index of research on photobiomodulation and light therapy, gathered from the world’s journals and trial registries.

Sections
Other

Photobiomodulation activates the PI3K/AKT pathway in diabetic fibroblast cells in vitro

Our findings suggest that the therapeutic effects of PBM in stressed cells are through activation of the PI3K/AKT cell signalling pathway and downstream GSK3β and mTOR signalling proteins.

Excerpt from the paper’s abstract. Read the full paper for the details.

AI-generated summary

The authors studied diabetic fibroblast cells grown in vitro and exposed them to 660 nm light at 5 J/cm2, then measured signaling proteins at 24 and 48 hours. They report increased activation of the PI3K/AKT pathway and downstream mTOR and GSK3β proteins in irradiated cells. The study used cell models only, not patients or animals.

Who or what was studied
Diabetic fibroblast cells grown in vitro
Wavelengths
660 nm
Limits stated in the abstract
The study used in vitro cell models only, so the findings may not apply to living tissue or patients.

Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.

Abstract

Photobiomodulation (PBM) has been known to facilitate the healing of numerous ailments including diabetic wounds. PBM is not broadly acknowledged largely due to scepticism regarding its mechanism of action, including the specific molecular targets and the effects rendered at a tissue, cellular and molecular level. Diabetes mellitus (DM) reduces cellular signalling, including the phosphatidylinositol 3 kinase/protein kinase B (PI3K/AKT) signalling pathway that is critical during wound healing. In DM, wound chronicity is common and may lead to non-traumatic limb amputation. This study investigated the hypothesis that PBM at 660 nm activates PI3K/AKT and downstream signalling proteins in fibroblast cells in vitro. Cells were incubated for 24 and 48 h after PBM (660 nm and 5 J/cm2), followed by evaluation of activated PI3K/AKT and downstream mammalian target of rapamycin (mTOR) and glycogen synthase kinase-3 beta (GSK3β) signalling proteins using western blotting and ELISA. Irradiated cell models displayed increased activation of PI3K/AKT and downstream mTOR and GSK3β signalling proteins. Our findings suggest that the therapeutic effects of PBM in stressed cells are through activation of the PI3K/AKT cell signalling pathway and downstream GSK3β and mTOR signalling proteins. This study provides a novel understanding into one of the probable molecular mechanisms in which PBM at a wavelength of 660 nm (5 J/cm2) enhances therapeutic activities in diabetic wound healing.

Abstract reproduced under the CC BY license. Source: PubMed, a service of the National Library of Medicine.

Light parameters mentioned

Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.

Wavelength
660 nm
Energy density (fluence)
5 J/cm2

How to read a single study: what to check before relying on this kind of research.

Terms in this paper: Photobiomodulation, Wound healing, Wavelength. Each links to its definition in the glossary.

A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.

Related studies